EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC 4.0

One‐year real‐world performance of the DBLG1 closed‐loop system: Data from 3706 adult users with type 1 diabetes in Germany

Pierre-Yves Benhamou iD, Alice Adenis, Hocine Lebbad, Yousra Tourki, Maria-Belen Heredia, Bernhard Gehr, Sylvia Franc iD, Guillaume Charpentier

Diabetes, Obesity and Metabolism · 2023

DOI: 10.1111/dom.15008 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Diabetes, Obesity and Metabolism, 2023. Verfasst von Pierre-Yves Benhamou und 7 weiteren Autor:innen. Beteiligte Einrichtung: Department of Endocrinology, Grenoble University Hospital, Grenoble Alpes University, INSERM U1055, LBFA, Grenoble, France. Hauptthemen laut MEDLINE: Diabetes Mellitus, Type 1, Hypoglycemia. Die Arbeit wurde bisher 33-mal zitiert (Crossref) und nennt 21 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Aim

The Diabeloop Generation 1 (DBLG1) system is an interoperable hybrid closed‐loop solution that was commercialized in Germany in March 2021. We report the longitudinal glycaemic outcomes among the first 3706 users in a real‐world setting.

Methods

We performed a retrospective data collection of all consenting adult patients with type 1 diabetes who were equipped in Germany with the DBLG1 system before 30 April 2022, and with a minimum 14 days of closed‐loop usage.

Results

In total, 3706 users (41% women, age 45.1 ± 14.5 years) met the inclusion criteria, reaching a mean follow‐up of 131.0 ± 85.1 days, an overall 485 600 days of continuous glucose monitoring data, and a median time spent in closed‐loop of 95.0% (IQR 89.1‐97.4). The median percentage time in range (70‐180 mg/dl) was 72.1% (IQR 65.0‐78.9); the time below 70 mg/dl was 0.9% (0.5‐1.7), the time below 54 mg/dl was 0.1% (0.1‐0.3), and the median Glucose Management Index was 7.0% (6.8‐7.3). Exploratory analysis of a subset of 2460 patients in whom baseline glycated haemoglobin (HbA1c) was available [7.4% (IQR 6.9‐8.0)] showed that the achieved mean time in range was influenced by baseline HbA1c, ranging from 65.8 ± 9.9% (A1c ≥8.5%) to 81.3 ± 6.8% (A1c

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Diabetes Mellitus, Type 1HypoglycemiaHumansAdultFemaleMiddle AgedMaleHypoglycemic AgentsGlycated HemoglobinBlood GlucoseBlood Glucose Self-MonitoringRetrospective StudiesInsulin Infusion SystemsInsulinGlucoseGermany

Stichwörter der Autor:innen

artificial pancreasautomated insulin deliveryclosed-loophyperglycaemiahypoglycaemiatime in rangetype 1 diabetes

Substanzen

Hypoglycemic AgentsGlycated HemoglobinBlood GlucoseInsulinGlucose

Autor:innen und Institutionen

  • Department of Endocrinology, Grenoble University Hospital, Grenoble Alpes University, INSERM U1055, LBFA, Grenoble, France.
  • Diabeloop SA, Paris, France.
  • Zentrum für Diabetes und Stoffwechselerkrankungen, m&i Fachklinik Bad Heilbrunn, Bad Heilbrunn, Germany.
  • CERITD (Center for Study and Research for Improvement of the Treatment of Diabetes), Bioparc-Genopole Evry-Corbeil, Evry, France.
  • Department of Diabetes and Endocrinology, Sud-Francilien Hospital, Corbeil, France.

ORCID-Profile: Pierre-Yves Benhamou, Sylvia Franc

Zitieren

APA

Benhamou, P. Y., Adenis, A., Lebbad, H., Tourki, Y., Heredia, M. B., Gehr, B., Franc, S., & Charpentier, G. (2023). One‐year real‐world performance of the DBLG1 closed‐loop system: Data from 3706 adult users with type 1 diabetes in Germany. Diabetes, Obesity and Metabolism. https://doi.org/10.1111/dom.15008

Vancouver

Benhamou PY, Adenis A, Lebbad H, Tourki Y, Heredia MB, Gehr B, et al. One‐year real‐world performance of the DBLG1 closed‐loop system: Data from 3706 adult users with type 1 diabetes in Germany. Diabetes, Obesity and Metabolism. 2023. doi:10.1111/dom.15008

BibTeX
@article{Benhamou2023,
  author = {Benhamou, Pierre-Yves and Adenis, Alice and Lebbad, Hocine and Tourki, Yousra and Heredia, Maria-Belen and Gehr, Bernhard and Franc, Sylvia and Charpentier, Guillaume},
  title = {One‐year real‐world performance of the DBLG1 closed‐loop system: Data from 3706 adult users with type 1 diabetes in Germany},
  journal = {Diabetes, Obesity and Metabolism},
  year = {2023},
  doi = {10.1111/dom.15008}
}
Kostenlos starten →